GlaxoSmithKline on Sunday said its board rejected a request from the Arab Company for Drug Industries & …
Tag:
Hikma Pharmaceuticals
-
-
FeatureIndustry & TradeTech/AI
Hikma, GlaxoSmithKline cease talks over potential deal to buy Egypt, Tunisia assets
GlaxoSmithKline said on Thursday that its majority shareholder Glaxo Group Limited and Hikma Pharmaceuticals have agreed to …
-
Egypt’s Rameda Pharmaceutical said in a bourse filling on Tuesday it had withdrawn its proposal to acquire …
-
FeatureIndustry & TradeTech/AI
GlaxoSmithKline in talks with Hikma to sell Egypt stake, rules out talks with Rameda
by Islam salahby Islam salahGlaxoSmithKline will focus its efforts and resources on discussing the sale of its stake in Egypt with …
-
Egypt’s Rameda Pharmaceutical said on Tuesday it had submitted a non-binding letter of intent to purchase GlaxoSmithKline’s …
-
FeatureIndustry & TradeTech/AI
GlaxoSmithKline allows Hikma Pharmaceuticals due diligence on Egypt, Tunisia assets
GlaxoSmithKline said on Wednesday its board of directors has allowed Hikma Pharmaceuticals, which is interested in buying …
-
Hikma Pharmaceuticals announced on Tuesday plans to buy GlaxoSmithKline’s stake in some assets including the drugmaker’s pharmaceutical, …
-
Banks
Egypt’s HC eyes completion of two more acquisitions before 2016-end
by Yomna Yasserby Yomna YasserEgypt’s investment bank, HC Securities and Investment plans to make two acquisitions totalling 700 million Egyptian pounds …
-
Egypt’s investment bank, HC Securities and Investment has managed acquisitions totalling 1.035 billion Egyptian pounds ($116.6 million) …